Darwin Global Management, Ltd. Aclaris Therapeutics, Inc. Transaction History

Darwin Global Management, Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$9.74 - $17.92 $2.11 Million - $3.87 Million	-216,143 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$12.27 - $18.49 $696,322 - $1.05 Million	56,750 Added 35.6%	216,143 $3.14 Million
Q3 2021 Nov 15, 2021	SELL	$13.38 - $18.8 $1.21 Million - $1.7 Million	-90,607 Reduced 36.24%	159,393 $2.87 Million
Q2 2021 Aug 16, 2021	BUY	$17.08 - $29.6 $4.27 Million - $7.4 Million	250,000 New	250,000 $4.39 Million

52.4M

32.4K

3.3K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $139M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Darwin Global Management, Ltd., based on Form 13F filings with the SEC.

Stay updated on Darwin Global Management, Ltd. with notifications on news.